PBYI | Puma Biotechnology Inc
Category: Biotechnology company
Quick infos Headquarters: Los Angeles, California, United States Trade prices Volume: Market Cap: 125.03M Prev closed: Open: 3.32 High: 3.38 Low: 3.08 52 week low: 2.06 52 week high: 11.95 Dividends: No Dividends Next ER: November 10, 2022
About the Company Puma Biotechnology is a publicly-traded pharmaceutical company headquartered in Los Angeles, CA. Puma in-licenses intermediate-stage drug candidates for further development. The company was founded in 2010. The current CEO is Alan Auerbach.
Earnings History Date EPS / Forecast Revenue / Forecast March 2, 2023 November 3, 2022 -0.01 / -0.075157.1M / 50.1MBeat! August 4, 2022 0.21 / 0.010259.5M / 52.62MBeat! May 5, 2022 -0.08 / -0.16645.7M / 45.07MBeat! March 3, 2022 0.1 / -0.087755.4M / 47.17MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Aug 16, 2022 3.270 3.440 3.440
3.250
247.96K -5.22% Aug 15, 2022 3.450 3.470 3.510
3.425
153.45K -1.71% Aug 12, 2022 3.510 3.540 3.610
3.470
194.95K -1.13% Aug 11, 2022 3.550 3.570 3.645
3.450
323.34K -0.56% Aug 10, 2022 3.570 3.700 3.740
3.530
383.50K -2.19% Aug 9, 2022 3.650 3.440 3.710
3.420
304.64K 4.58% Aug 8, 2022 3.490 3.910 4.070
3.450
756.91K -9.11% Aug 5, 2022 3.840 3.400 3.900
3.255
673.07K 17.43% Aug 4, 2022 3.270 3.110 3.345
3.080
285.83K 5.14% Aug 3, 2022 3.110 3.010 3.285
3.010
286.98K 5.42% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:2007 Employees:160 News
Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results finance.yahoo.com Sep 21, 2022 4:05 pm
Puma Biotechnology Reports Second Quarter 2022 Financial Results finance.yahoo.com Sep 21, 2022 4:05 pm
Is Puma Biotechnology, Inc. (NASDAQ:PBYI) Popular Amongst Insiders? finance.yahoo.com Sep 21, 2022 8:47 am Puma Biotechnology, Takeda enter licensing agreement for cancer treatment alisertib seekingalpha.com Sep 21, 2022 4:37 am
Puma Biotechnology Announces Exclusive License Agreement with Takeda for the Development and Commercialization of Alisertib, an Investigational Aurora Kinase A Inhibitor finance.yahoo.com Sep 20, 2022 4:05 pm
Puma Biotechnology to Present at the H.C. Wainwright 24th Annual Global Investment Conference finance.yahoo.com Sep 6, 2022 4:15 pm
Why Puma Biotechnology Shares Dropped 17.7% This Week fool.com Sep 1, 2022 6:33 pm
Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Profit Outlook finance.yahoo.com Aug 12, 2022 6:33 am
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com Aug 5, 2022 5:15 pm Puma Biotechnology Non-GAAP EPS of $0.28, revenue of $59.5M seekingalpha.com Aug 5, 2022 4:44 am Puma Biotechnology Q2 2022 Earnings Preview seekingalpha.com Aug 4, 2022 5:35 am
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com May 11, 2022 5:31 pm
Puma Biotech (PBYI) Reports Q1 Loss, Misses Revenue Estimates finance.yahoo.com May 5, 2022 6:05 pm
Voyager Therapeutics (VYGR) Reports Q1 Loss, Misses Revenue Estimates finance.yahoo.com May 4, 2022 5:35 pm
Puma Biotechnology Announces Publication of Neratinib Abstract Titles for the 2022 ASCO Annual Meeting finance.yahoo.com Apr 27, 2022 4:15 pm
Puma Biotechnology Announces $10 Million Private Placement finance.yahoo.com Mar 10, 2022 8:30 am
Market Sentiment Around Loss-Making Puma Biotechnology, Inc. (NASDAQ:PBYI) finance.yahoo.com Mar 5, 2022 6:13 am
Puma Biotechnology Presents Updated Results from the Phase II SUMMIT Trial of Neratinib for HER2-Mutant, HR-Positive Metastatic Breast Cancer at SABCS 2020 finance.yahoo.com Mar 4, 2022 5:03 pm
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com Mar 4, 2022 5:00 pm
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com Jul 6, 2022 5:15 pm This company doesn't provide a dividend.
Key Persons Talk about Puma Biotechnology Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written. -- Warren Buffet